APA (7th ed.) Citation

SS, O., Jr, M. R., SW, B., TH, C., T, L., RJ, M., . . . RZ, L. (2025). Preliminary effects of oral ANS-6637, an ALDH2 inhibitor, on cue-induced craving, safety and alcohol consumption among adults with alcohol use disorder: A proof-of-concept, randomized, human laboratory trial. Alcohol and alcoholism (Oxford, Oxfordshire), 60(2), . https://doi.org/10.1093/alcalc/agaf001

Chicago Style (17th ed.) Citation

SS, O'Malley, et al. "Preliminary Effects of Oral ANS-6637, an ALDH2 Inhibitor, on Cue-induced Craving, Safety and Alcohol Consumption Among Adults with Alcohol Use Disorder: A Proof-of-concept, Randomized, Human Laboratory Trial." Alcohol and Alcoholism (Oxford, Oxfordshire) 60, no. 2 (2025). https://doi.org/10.1093/alcalc/agaf001.

MLA (9th ed.) Citation

SS, O'Malley, et al. "Preliminary Effects of Oral ANS-6637, an ALDH2 Inhibitor, on Cue-induced Craving, Safety and Alcohol Consumption Among Adults with Alcohol Use Disorder: A Proof-of-concept, Randomized, Human Laboratory Trial." Alcohol and Alcoholism (Oxford, Oxfordshire), vol. 60, no. 2, 2025, https://doi.org/10.1093/alcalc/agaf001.